Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
June-2020 Volume 19 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
June-2020 Volume 19 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

Elevated mRNA expression levels of DLGAP5 are associated with poor prognosis in breast cancer

  • Authors:
    • Tao Xu
    • Menglu Dong
    • Hanning Li
    • Rui Zhang
    • Xingrui Li
  • View Affiliations / Copyright

    Affiliations: Department of Thyroid and Breast Surgery, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China
    Copyright: © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 4053-4065
    |
    Published online on: April 10, 2020
       https://doi.org/10.3892/ol.2020.11533
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Breast cancer is the most commonly diagnosed type of cancer and one of the leading causes of cancer‑associated mortality in women. In addition, the underlying molecular mechanisms of the occurrence and development of breast cancer requires further investigation. In the present study, bioinformatics analysis was performed to identify differentially expressed genes (DEGs) between breast cancer and normal breast tissues to investigate the underlying molecular mechanisms. In addition, reverse transcription‑quantitative PCR and immunohistochemistry (IHC) were performed to investigate the protein and mRNA expression levels of a specific DEG, discs large‑associated protein 5 (DLGAP5). A Cell Counting Kit‑8 assay and flow cytometry analysis were used to assess the effects of DLGAP5 on cell proliferation. In total, 85 DEGs were identified in the three Gene Expression Omnibus datasets, including 40 upregulated and 45 downregulated genes. In addition, 30 hub genes were identified following the construction of a protein‑protein interaction network, and 28 of the 30 hub genes were established to be indicators of breast cancer prognosis. DLGAP5 was highly expressed in breast cancer specimens, and its expression levels were correlated with clinical stage and lymph node status. In addition, downregulation of DLGAP5 repressed the proliferation of breast cancer MDA‑MB‑231 cells and induced cell cycle arrest. Additionally, DLGAP5 was identified to be localized in the mitochondria, and the presence of a conserved microtubule‑associated proteins 1A/1B light chain 3B‑interacting region motif suggested that DLGAP5 may serve a role in mitophagy. The present results demonstrated an association between DLGAP5 expression levels and the clinicopathological characteristics of patients with breast cancer using IHC. In conclusion, DLGAP5 may be a promising target in the diagnosis and treatment of breast cancer.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

View References

1 

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI

2 

DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Goding Sauer A, Jemal A and Siegel RL: Breast cancer statistics, 2019. CA Cancer J Clin. 69:438–451. 2019. View Article : Google Scholar : PubMed/NCBI

3 

Mubarik S, Malik SS, Wang Z, Li C, Fawad M and Yu C: Recent insights into breast cancer incidence trends among four Asian countries using age-period-cohort model. Cancer Manag Res. 11:8145–8155. 2019. View Article : Google Scholar : PubMed/NCBI

4 

Tang L, Chen Y, Tang X, Wei D, Xu X and Yan F: Long noncoding RNA DCST1-AS1 promotes cell proliferation and metastasis in triple-negative breast cancer by forming a positive regulatory loop with miR-873-5p and MYC. J Cancer. 11:311–323. 2020. View Article : Google Scholar : PubMed/NCBI

5 

Gruosso T, Gigoux M, Manem VSK, Bertos N, Zuo D, Perlitch I, Saleh SMI, Zhao H, Souleimanova M, Johnson RM, et al: Spatially distinct tumor immune microenvironments stratify triple-negative breast cancers. J Clin Invest. 129:1785–1800. 2019. View Article : Google Scholar : PubMed/NCBI

6 

Chen DQ, Kong XS, Shen XB, Huang MZ, Zheng JP, Sun J and Xu SH: Identification of differentially expressed genes and signaling pathways in acute myocardial infarction based on integrated bioinformatics analysis. Cardiovasc Ther. 2019:84907072019. View Article : Google Scholar : PubMed/NCBI

7 

Võsa U, Kolde R, Vilo J, Metspalu A and Annilo T: Comprehensive meta-analysis of microRNA expression using a robust rank aggregation approach. Methods Mol Biol. 1182:361–373. 2014. View Article : Google Scholar : PubMed/NCBI

8 

Kolde R, Laur S, Adler P and Vilo J: Robust rank aggregation for gene list integration and meta-analysis. Bioinformatics. 28:573–580. 2012. View Article : Google Scholar : PubMed/NCBI

9 

Hewit K, Sandilands E, Martinez RS, James D, Leung HY, Bryant DM, Shanks E and Markert EK: A functional genomics screen reveals a strong synergistic effect between docetaxel and the mitotic gene DLGAP5 that is mediated by the androgen receptor. Cell Death Dis. 9:10692018. View Article : Google Scholar : PubMed/NCBI

10 

Wang Q, Chen Y, Feng H, Zhang B and Wang H: Prognostic and predictive value of HURP in non-small cell lung cancer. Oncol Rep. 39:1682–1692. 2018.PubMed/NCBI

11 

Eissa S, Matboli M, Mansour A, Mohamed S, Awad N and Kotb YM: Evaluation of urinary HURP mRNA as a marker for detection of bladder cancer: Relation to bilharziasis. Med Oncol. 31:8042014. View Article : Google Scholar : PubMed/NCBI

12 

Espinoza I, Sakiyama MJ, Ma T, Fair L, Zhou X, Hassan M, Zabaleta J and Gomez CR: Hypoxia on the expression of hepatoma upregulated protein in prostate cancer cells. Front Oncol. 6:1442016. View Article : Google Scholar : PubMed/NCBI

13 

Tsou AP, Yang CW, Huang CYF, Yu RC, Lee YC, Chang CW, Chen BR, Chung YF, Fann MJ, Chi CW, et al: Identification of a novel cell cycle regulated gene, HURP, overexpressed in human hepatocellular carcinoma. Oncogene. 22:298–307. 2003. View Article : Google Scholar : PubMed/NCBI

14 

Hatfield KJ, Reikvam H and Bruserud Ø: Identification of a subset of patients with acute myeloid leukemia characterized by long-term in vitro proliferation and altered cell cycle regulation of the leukemic cells. Expert Opin Ther Targets. 18:1237–1251. 2014. View Article : Google Scholar : PubMed/NCBI

15 

Kretschmer C, Sterner-Kock A, Siedentopf F, Schoenegg W, Schlag PM and Kemmner W: Identification of early molecular markers for breast cancer. Mol Cancer. 10:152011. View Article : Google Scholar : PubMed/NCBI

16 

Aswad L, Yenamandra SP, Ow GS, Grinchuk O, Ivshina AV and Kuznetsov VA: Genome and transcriptome delineation of two major oncogenic pathways governing invasive ductal breast cancer development. Oncotarget. 6:36652–36674. 2015. View Article : Google Scholar : PubMed/NCBI

17 

R Development Core Team, . R: A Language and Environment for Statistical Computing, Version 3.0.1 (2013-05-16). R Foundation Statistical Compututing; Vienna, Austria: 2013, Available online. https://www.R-project.orgNovember 1–2013

18 

Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W and Smyth GK: Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43:e472015. View Article : Google Scholar : PubMed/NCBI

19 

Lu S, Zhao R, Shen J, Zhang Y, Shi J, Xu C, Chen J, Lin R, Han W and Luo D: Integrated bioinformatics analysis to screen hub genes in the lymph node metastasis of thyroid cancer. Oncol Lett. 19:1375–1383. 2020.PubMed/NCBI

20 

Yang J, Han S, Huang W, Chen T, Liu Y, Pan S and Li S: A meta-analysis of microRNA expression in liver cancer. PLoS One. 9:e1145332014. View Article : Google Scholar : PubMed/NCBI

21 

Li C, Yin Y, Liu X, Xi X, Xue W and Qu Y: Non-small cell lung cancer associated microRNA expression signature: Integrated bioinformatics analysis, validation and clinical significance. Oncotarget. 8:24564–24578. 2017.PubMed/NCBI

22 

Zhang C, Hu X, Qi F, Luo J and Li X: Identification of CD2, CCL5 and CCR5 as potential therapeutic target genes for renal interstitial fibrosis. Ann Transl Med. 7:4542019. View Article : Google Scholar : PubMed/NCBI

23 

Huang da W, Sherman BT and Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI

24 

Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos A, Tsafou KP, et al: STRING v10: Protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 43:(Database Issue). D447–D452. 2015. View Article : Google Scholar : PubMed/NCBI

25 

Bader GD and Hogue CW: An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics. 4:22003. View Article : Google Scholar : PubMed/NCBI

26 

Nagy Á, Lánczky A, Menyhárt O and Győrffy B: Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets. Sci Rep. 8:92272018. View Article : Google Scholar : PubMed/NCBI

27 

Ringnér M, Fredlund E, Häkkinen J, Borg Å and Staaf J: GOBO: Gene expression-based outcome for breast cancer online. PLoS One. 6:e179112011. View Article : Google Scholar : PubMed/NCBI

28 

Lemler DJ, Lynch ML, Tesfay L, Deng Z, Paul BT, Wang X, Hegde P, Manz DH, Torti SV and Torti FM: DCYTB is a predictor of outcome in breast cancer that functions via iron-independent mechanisms. Breast Cancer Res. 19:252017. View Article : Google Scholar : PubMed/NCBI

29 

Parker JS, Mullins M, Cheang MC, Leung S, Voduc D, Vickery T, Davies S, Fauron C, He X, Hu Z, et al: Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol. 27:1160–1167. 2009. View Article : Google Scholar : PubMed/NCBI

30 

Loi S, Haibe-Kains B, Desmedt C, Lallemand F, Tutt AM, Gillet C, Ellis P, Harris A, Bergh J, Foekens JA, et al: Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade. J Clin Oncol. 25:1239–1246. 2007. View Article : Google Scholar : PubMed/NCBI

31 

Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, Viale A, Olshen AB, Gerald WL and Massagué J: Genes that mediate breast cancer metastasis to lung. Nature. 436:518–524. 2005. View Article : Google Scholar : PubMed/NCBI

32 

Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, Yang F, Talantov D, Timmermans M, Meijer-van Gelder ME, Yu J, et al: Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet. 365:671–679. 2005. View Article : Google Scholar : PubMed/NCBI

33 

Schmidt M, Böhm D, von Törne C, Steiner E, Puhl A, Pilch H, Lehr HA, Hengstler JG, Kölbl H and Gehrmann M: The humoral immune system has a key prognostic impact in node-negative breast cancer. Cancer Res. 68:5405–5413. 2008. View Article : Google Scholar : PubMed/NCBI

34 

Minn AJ, Gupta GP, Padua D, Bos P, Nguyen DX, Nuyten D, Kreike B, Zhang Y, Wang Y, Ishwaran H, et al: Lung metastasis genes couple breast tumor size and metastatic spread. Proc Natl Acad Sci USA. 104:6740–6745. 2007. View Article : Google Scholar : PubMed/NCBI

35 

Yu S, Jiang X, Li J, Li C, Guo M, Ye F, Zhang M, Jiao Y and Guo B: Comprehensive analysis of the GATA transcription factor gene family in breast carcinoma using gene microarrays, online databases and integrated bioinformatics. Sci Rep. 9:44672019. View Article : Google Scholar : PubMed/NCBI

36 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

37 

Lee SC, Jain PA, Jethwa SC, Tripathy D and Yamashita MW: Radiologists' role in breast cancer staging: Providing key information for clinicians. Radiographics. 34:330–342. 2014. View Article : Google Scholar : PubMed/NCBI

38 

Stelzer G, Rosen N, Plaschkes I, Zimmerman S, Twik M, Fishilevich S, Stein TI, Nudel R, Lieder I, Mazor Y, et al: The genecards suite: From gene data mining to disease genome sequence analyses. Curr Protoc Bioinformatics. 54:1.30.1–1.30.33. 2016. View Article : Google Scholar

39 

Kalvari I, Tsompanis S, Mulakkal NC, Osgood R, Johansen T, Nezis IP and Promponas VJ: iLIR: A web resource for prediction of Atg8-family interacting proteins. Autophagy. 10:913–925. 2014. View Article : Google Scholar : PubMed/NCBI

40 

Jacomin AC, Samavedam S, Promponas V and Nezis IP: iLIR database: A web resource for LIR motif-containing proteins in eukaryotes. Autophagy. 12:1945–1953. 2016. View Article : Google Scholar : PubMed/NCBI

41 

Zhang Y, Yao Y, Qiu X, Wang G, Hu Z, Chen S, Wu Z, Yuan N, Gao H, Wang J, et al: Listeria hijacks host mitophagy through a novel mitophagy receptor to evade killing. Nat Immunol. 20:433–446. 2019. View Article : Google Scholar : PubMed/NCBI

42 

Jian L and Yang G: Identification of key genes involved in diabetic peripheral neuropathy progression and associated with pancreatic cancer. Diabetes Metab Syndr Obes. 13:463–476. 2020. View Article : Google Scholar : PubMed/NCBI

43 

Yu CT, Hsu JM, Lee YC, Tsou AP, Chou CK and Huang CY: Phosphorylation and Stabilization of HURP by Aurora-A: Implication of HURP as a Transforming Target of Aurora-A. Mol Cell Biol. 25:5789–5800. 2005. View Article : Google Scholar : PubMed/NCBI

44 

Branchi V, García SA, Radhakrishnan P, Győrffy B, Hissa B, Schneider M, Reißfelder C and Schölch S: Prognostic value of DLGAP5 in colorectal cancer. Int J Colorectal Dis. 34:1455–1465. 2019. View Article : Google Scholar : PubMed/NCBI

45 

Schneider MA, Christopoulos P, Muley T, Warth A, Klingmueller U, Thomas M, Herth FJ, Dienemann H, Mueller NS, Theis F and Meister M: AURKA, DLGAP5, TPX2, KIF11 and CKAP5: Five specific mitosis-associated genes correlate with poor prognosis for non-small cell lung cancer patients. Int J Oncol. 50:365–372. 2017. View Article : Google Scholar : PubMed/NCBI

46 

Shi YX, Yin JY, Shen Y, Zhang W, Zhou HH and Liu ZQ: Genome-scale analysis identifies NEK2, DLGAP5 and ECT2 as promising diagnostic and prognostic biomarkers in human lung cancer. Sci Rep. 7:80722017. View Article : Google Scholar : PubMed/NCBI

47 

Tagal V, Wei S, Zhang W, Brekken RA, Posner BA, Peyton M, Girard L, Hwang T, Wheeler DA, Minna JD, et al: SMARCA4-inactivating mutations increase sensitivity to Aurora kinase A inhibitor VX-680 in non-small cell lung cancers. Nat Commun. 8:140982017. View Article : Google Scholar : PubMed/NCBI

48 

Yamamoto S, Takayama K, Obinata D, Fujiwara K, Ashikari D, Takahashi S and Inoue S: Identification of new octamer transcription factor 1-target genes upregulated in castration-resistant prostate cancer. Cancer Sci. 110:3476–3485. 2019. View Article : Google Scholar : PubMed/NCBI

49 

Kim D and Cho JY: NQO1 is required for β-lapachone-mediated downregulation of breast-cancer stem-cell activity. Int J Mol Sci. 19(pii): E38132018. View Article : Google Scholar : PubMed/NCBI

50 

Freedman RA, Keating NL, Lin NU, Winer EP, Vaz-Luis I, Lii J, Exman P and Barry WT: Breast cancer-specific survival by age: Worse outcomes for the oldest patients. Cancer. 124:2184–2191. 2018. View Article : Google Scholar : PubMed/NCBI

51 

Del Prete S, Caraglia M, Luce A, Montella L, Galizia G, Sperlongano P, Cennamo G, Lieto E, Capasso E, Fiorentino O, et al: Clinical and pathological factors predictive of response to neoadjuvant chemotherapy in breast cancer: A single center experience. Oncol Lett. 18:3873–3879. 2019.PubMed/NCBI

52 

Hueman MT, Wang H, Yang CQ, Sheng L, Henson DE, Schwartz AM and Chen D: Creating prognostic systems for cancer patients: A demonstration using breast cancer. Cancer Med. 7:3611–3621. 2018. View Article : Google Scholar : PubMed/NCBI

53 

Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, et al: SEER Cancer Statistics Review, 1975–2016. National Cancer Institute; Bethesda, MD, USA:

54 

Nechuta S, Lu W, Zheng Y, Cai H, Bao PP, Gu K, Zheng W and Shu XO: Comorbidities and breast cancer survival: A report from the Shanghai breast cancer survival study. Breast Cancer Res Treat. 139:227–235. 2013. View Article : Google Scholar : PubMed/NCBI

55 

Kuo TC, Chang PY, Huang SF, Chou CK and Chao CC: Knockdown of HURP inhibits the proliferation of hepacellular carcinoma cells via downregulation of gankyrin and accumulation of p53. Biochem Pharmacol. 83:758–768. 2012. View Article : Google Scholar : PubMed/NCBI

56 

Zhang X, Pan Y, Fu H and Zhang J: Nucleolar and spindle associated protein 1 (NUSAP1) inhibits cell proliferation and enhances susceptibility to epirubicin in invasive breast cancer cells by regulating cyclin D kinase (CDK1) and DLGAP5 expression. Med Sci Monit. 24:8553–8564. 2018. View Article : Google Scholar : PubMed/NCBI

57 

Zhong Z, Sanchez-Lopez E and Karin M: Autophagy, inflammation, and immunity: A Troika governing cancer and its treatment. Cell. 166:288–298. 2016. View Article : Google Scholar : PubMed/NCBI

58 

Rybstein MD, Bravo-San Pedro JM, Kroemer G and Galluzzi L: The autophagic network and cancer. Nat Cell Biol. 20:243–251. 2018. View Article : Google Scholar : PubMed/NCBI

59 

Palikaras K, Lionaki E and Tavernarakis N: Coordination of mitophagy and mitochondrial biogenesis during ageing in C. Elegans. Nature. 521:525–528. 2015. View Article : Google Scholar : PubMed/NCBI

60 

Lu H, Li G, Liu L, Feng L, Wang X and Jin H: Regulation and function of mitophagy in development and cancer. Autophagy. 9:1720–1736. 2013. View Article : Google Scholar : PubMed/NCBI

61 

Chourasia AH and Macleod KF: Tumor suppressor functions of BNIP3 and mitophagy. Autophagy. 11:1937–1938. 2015. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Xu T, Dong M, Li H, Zhang R and Li X: Elevated mRNA expression levels of DLGAP5 are associated with poor prognosis in breast cancer. Oncol Lett 19: 4053-4065, 2020.
APA
Xu, T., Dong, M., Li, H., Zhang, R., & Li, X. (2020). Elevated mRNA expression levels of DLGAP5 are associated with poor prognosis in breast cancer. Oncology Letters, 19, 4053-4065. https://doi.org/10.3892/ol.2020.11533
MLA
Xu, T., Dong, M., Li, H., Zhang, R., Li, X."Elevated mRNA expression levels of DLGAP5 are associated with poor prognosis in breast cancer". Oncology Letters 19.6 (2020): 4053-4065.
Chicago
Xu, T., Dong, M., Li, H., Zhang, R., Li, X."Elevated mRNA expression levels of DLGAP5 are associated with poor prognosis in breast cancer". Oncology Letters 19, no. 6 (2020): 4053-4065. https://doi.org/10.3892/ol.2020.11533
Copy and paste a formatted citation
x
Spandidos Publications style
Xu T, Dong M, Li H, Zhang R and Li X: Elevated mRNA expression levels of DLGAP5 are associated with poor prognosis in breast cancer. Oncol Lett 19: 4053-4065, 2020.
APA
Xu, T., Dong, M., Li, H., Zhang, R., & Li, X. (2020). Elevated mRNA expression levels of DLGAP5 are associated with poor prognosis in breast cancer. Oncology Letters, 19, 4053-4065. https://doi.org/10.3892/ol.2020.11533
MLA
Xu, T., Dong, M., Li, H., Zhang, R., Li, X."Elevated mRNA expression levels of DLGAP5 are associated with poor prognosis in breast cancer". Oncology Letters 19.6 (2020): 4053-4065.
Chicago
Xu, T., Dong, M., Li, H., Zhang, R., Li, X."Elevated mRNA expression levels of DLGAP5 are associated with poor prognosis in breast cancer". Oncology Letters 19, no. 6 (2020): 4053-4065. https://doi.org/10.3892/ol.2020.11533
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team